Literature DB >> 15166989

Ex vivo transduction of microvascular free flaps for localized peptide delivery.

Joseph Michaels1, Michael Dobryansky, Robert D Galiano, Daniel J Ceradini, Robert Bonillas, Deirdre Jones, Natalie Seiser, Jamie P Levine, Geoffrey C Gurtner.   

Abstract

Gene therapy is a promising modality for the treatment of soft tissue malignancies. Our laboratory has developed a novel technique of gene transfer using microvascular free flaps that addresses many of the current barriers preventing gene therapy from achieving widespread clinical use. Our previous work has demonstrated our ability to transduce free flaps with an adenovirus encoding the reporter gene lacZ. In this current study, we show that microvascular free flaps can be transduced with an adenovirus encoding the angiogenesis inhibitor endostatin with high levels of local flap expression. These transduced free flaps were able to serve as "biologic pumps" and were able to secrete endostatin into the serum as demonstrated by enzyme-linked immunosorbent assay. This form of "biologic brachytherapy" could provide a novel approach for the continuous delivery of therapeutic genes to a localized area while avoiding many of the practical obstacles currently limiting gene therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166989     DOI: 10.1097/01.sap.0000122652.81844.37

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

Review 1.  Regenerative surgery: tissue engineering in general surgical practice.

Authors:  Victor W Wong; Derrick C Wan; Geoffrey C Gurtner; Michael T Longaker
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

Review 2.  Cord-blood mesenchymal stem cells and tissue engineering.

Authors:  Curtis L Cetrulo
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

3.  Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models.

Authors:  K H Carruthers; G Metzger; M J During; A Muravlev; C Wang; E Kocak
Journal:  Cancer Gene Ther       Date:  2014-09-19       Impact factor: 5.987

4.  Fat grafting as a vehicle for the delivery of recombinant adenoassociated viral vectors to achieve gene modification of muscle flaps.

Authors:  Katherine H Carruthers; Matthew J During; Alexander Muravlev; Chuansong Wang; Ergun Kocak
Journal:  Ann Plast Surg       Date:  2013-06       Impact factor: 1.539

5.  Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.

Authors:  Aadil A Khan; James T Paget; Martin McLaughlin; Joan N Kyula; Michelle J Wilkinson; Timothy Pencavel; David Mansfield; Victoria Roulstone; Rohit Seth; Martin Halle; Navita Somaiah; Jessica K R Boult; Simon P Robinson; Hardev S Pandha; Richard G Vile; Alan A Melcher; Paul A Harris; Kevin J Harrington
Journal:  Sci Transl Med       Date:  2018-01-24       Impact factor: 17.956

6.  Utilization of a genetically modified muscle flap for local BMP-2 production and its effects on bone healing: a histomorphometric and radiological study in a rat model.

Authors:  Florian M Lampert; Arash Momeni; Filip Filev; Nestor Torio-Padron; Günter Finkenzeller; G Björn Stark; Dominik Steiner; Georgios Koulaxouzidis
Journal:  J Orthop Surg Res       Date:  2015-04-29       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.